Lepu Biotech, a Chinese biotechnology firm specialized in tumor immunotherapy, has raised RMB900 million (US$131.47 million) in a series A round of financing led by the country’s healthcare-focused private equity firm Shiyu Capital, according to a statement released on Monday. Returning investor Lepu Medical, Chinese medical devices manufacturer Lecheng Medical Care, and Chinese investment companies […]
Chinese PE Firm Shiyu Capital Leads $131M Series A Round In Biotech Start-Up comes originally from China Money Network. All Rights Reserved.